Waters beats top-line and bottom-line estimates; initiates Q1 and FY26 outlook
Source: SeekingAlpha
2026-02-09 06:43:47 ET
More on Waters
- Waters Corporation: Bigger, Better, But Fairly Priced
- Waters Corporation (WAT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Waters Corporation (WAT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Federal appeals court rejects NIH research funding cuts
- Waters raised to Outperform at Wolfe on BD Life Sciences deal
Read the full article on Seeking Alpha
For further details see:
Waters beats top-line and bottom-line estimates; initiates Q1 and FY26 outlook
Waters Corporation
NASDAQ: WAT
WAT Trading
-2.0% G/L:
$296.36 Last:
283,060 Volume:
$301 Open:
WAT Latest News
March 09, 2026 08:00:00 am
Waters Flagship ARES?G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed
WAT Stock Data
$19,462,563,078
58,952,201
0.08%
377
N/A
Biotechnology & Life Sciences
Healthcare
US
Milford
